tiprankstipranks
Trending News
More News >
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
UK Market

Circassia Pharmaceuticals (NIOX) Ratios

Compare
13 Followers

Circassia Pharmaceuticals Ratios

GB:NIOX's free cash flow for Q4 2024 was £0.62. For the 2024 fiscal year, GB:NIOX's free cash flow was decreased by £ and operating cash flow was £0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.41 4.65 3.41 1.83 1.11
Quick Ratio
2.97 3.99 2.97 1.58 0.96
Cash Ratio
2.11 2.76 2.11 1.17 0.28
Solvency Ratio
1.25 1.96 1.25 0.43 -0.66
Operating Cash Flow Ratio
0.73 1.61 0.73 0.13 -0.90
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
£ 14.80M£ 25.80M£ 14.80M£ 200.00K£ -7.30M
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.01 0.01 0.02 0.02
Debt-to-Equity Ratio
0.01 0.01 0.01 0.02 0.02
Debt-to-Capital Ratio
0.01 0.01 0.01 0.02 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.20 1.09 1.20 1.29 1.56
Debt Service Coverage Ratio
190.00 70.50 190.00 75.00 -175.00
Interest Coverage Ratio
18.00 23.00 18.00 -43.00 -173.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-1.19 -2.16 -1.19 -3.65 0.64
Profitability Margins
Gross Profit Margin
70.93%72.01%70.93%68.10%68.20%
EBIT Margin
5.75%11.41%5.75%-7.17%-75.73%
EBITDA Margin
49.20%23.64%49.20%11.11%-38.08%
Operating Profit Margin
5.75%12.50%5.75%-15.41%-72.38%
Pretax Profit Margin
33.55%11.14%33.55%-7.53%-76.99%
Net Profit Margin
51.44%29.08%51.44%12.90%-140.17%
Continuous Operations Profit Margin
45.05%25.82%45.05%8.24%-112.13%
Net Income Per EBT
153.33%260.98%153.33%-171.43%182.07%
EBT Per EBIT
583.33%89.13%583.33%48.84%106.36%
Return on Assets (ROA)
16.35%11.69%16.35%4.17%-32.49%
Return on Equity (ROE)
19.66%12.77%19.66%5.39%-50.68%
Return on Capital Employed (ROCE)
2.02%5.46%2.02%-5.69%-22.64%
Return on Invested Capital (ROIC)
2.69%12.55%2.69%6.20%-32.64%
Return on Tangible Assets
26.22%18.23%26.22%8.13%-63.57%
Earnings Yield
0.11%0.04%0.11%0.02%-0.31%
Efficiency Ratios
Receivables Turnover
8.46 8.98 8.46 10.73 1.48
Payables Turnover
18.20 9.36 18.20 17.80 1.46
Inventory Turnover
2.22 2.15 2.22 3.30 1.90
Fixed Asset Turnover
28.45 26.29 28.45 19.93 17.07
Asset Turnover
0.32 0.40 0.32 0.32 0.23
Working Capital Turnover Ratio
2.01 1.52 2.01 4.65 4.78
Cash Conversion Cycle
187.54 171.78 187.54 124.24 188.25
Days of Sales Outstanding
43.15 40.67 43.15 34.01 245.88
Days of Inventory Outstanding
164.45 170.10 164.45 110.73 192.11
Days of Payables Outstanding
20.05 38.98 20.05 20.51 249.74
Operating Cycle
207.60 210.76 207.60 144.74 437.98
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 0.03 0.02 <0.01 -0.06
Free Cash Flow Per Share
0.02 0.03 0.02 <0.01 -0.06
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.97 0.99 0.86 1.02
Dividend Paid and CapEx Coverage Ratio
67.00 1.07 67.00 7.00 -47.80
Capital Expenditure Coverage Ratio
67.00 38.67 67.00 7.00 -47.80
Operating Cash Flow Coverage Ratio
6.70 10.55 6.70 1.08 -14.94
Operating Cash Flow to Sales Ratio
0.21 0.32 0.21 0.05 -1.00
Free Cash Flow Yield
0.04%0.04%0.04%<0.01%-0.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
950.36 2.63K 950.36 4.65K -321.45
Price-to-Sales (P/S) Ratio
488.84 765.05 488.84 600.42 450.56
Price-to-Book (P/B) Ratio
186.82 335.96 186.82 250.77 162.91
Price-to-Free Cash Flow (P/FCF) Ratio
2.32K 2.49K 2.32K 13.96K -441.33
Price-to-Operating Cash Flow Ratio
2.28K 2.43K 2.28K 11.97K -450.56
Price-to-Earnings Growth (PEG) Ratio
2.78 -78.32 2.78 -42.33 -3.39
Price-to-Fair Value
186.82 335.96 186.82 250.77 162.91
Enterprise Value Multiple
992.36 3.23K 992.36 5.40K -1.18K
Enterprise Value
15.28B 28.13B 15.28B 16.74B 10.76B
EV to EBITDA
992.36 3.23K 992.36 5.40K -1.18K
EV to Sales
488.25 764.54 488.25 600.02 450.32
EV to Free Cash Flow
2.32K 2.49K 2.32K 13.95K -441.09
EV to Operating Cash Flow
2.28K 2.43K 2.28K 11.96K -450.32
Tangible Book Value Per Share
0.11 0.12 0.11 0.06 0.04
Shareholders’ Equity Per Share
0.20 0.20 0.20 0.16 0.17
Tax and Other Ratios
Effective Tax Rate
-0.34 -1.32 -0.34 2.10 -0.46
Revenue Per Share
0.07 0.09 0.07 0.07 0.06
Net Income Per Share
0.04 0.03 0.04 <0.01 -0.09
Tax Burden
1.53 2.61 1.53 -1.71 1.82
Interest Burden
5.83 0.98 5.83 1.05 1.02
Research & Development to Revenue
0.10 0.06 0.10 0.16 0.28
SG&A to Revenue
0.24 0.23 0.24 0.24 0.43
Stock-Based Compensation to Revenue
0.03 0.07 0.03 0.01 0.08
Income Quality
0.54 2.19 0.54 -1.75 0.95
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis